4//SEC Filing
MACAN WILLIAM ANDREW 4
Accession 0001062993-23-023059
CIK 0001227636other
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 7:42 PM ET
Size
8.9 KB
Accession
0001062993-23-023059
Insider Transaction Report
Form 4
MACAN WILLIAM ANDREW
EVP, GC, CCO and CS
Transactions
- Sale
Common Stock
2023-12-21$2.52/sh−11,663$29,391→ 348,742 total - Sale
Common Stock
2023-12-20$2.70/sh−11,664$31,493→ 360,405 total - Sale
Common Stock
2023-12-19$2.24/sh−11,664$26,127→ 372,069 total
Footnotes (4)
- [F1]The sales reported in this Form 4 were pursuant to a 10b5-1 plan validly adopted by the reporting person on on August 28, 2023.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.13 to $2.50. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.42 to $2.90. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.46 to $2.61. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Issuer
Neuronetics, Inc.
CIK 0001227636
Entity typeother
Related Parties
1- filerCIK 0001758584
Filing Metadata
- Form type
- 4
- Filed
- Dec 20, 7:00 PM ET
- Accepted
- Dec 21, 7:42 PM ET
- Size
- 8.9 KB